WO2007026035A3 - Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant - Google Patents
Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant Download PDFInfo
- Publication number
- WO2007026035A3 WO2007026035A3 PCT/ES2006/000488 ES2006000488W WO2007026035A3 WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3 ES 2006000488 W ES2006000488 W ES 2006000488W WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- porphyra
- mycosporin
- amino acid
- antioxidant
- type amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a mycosporin-type amino acid (porphyra 334) which can be used as an antioxidant and which is suitable for use in the biotechnological industry. The invention outlines the potential use of a mycosporin (MAA)-type amino acid as an antioxidant substance, specifically porphyra 334 isolated from red alga Porphyra leucostica, and to the possible use thereof in pharmaceutical, nutraceutical or functional food preparations, among others, for the prevention of oxidative stress.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502161A ES2301293B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. |
ESP200502161 | 2005-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007026035A2 WO2007026035A2 (en) | 2007-03-08 |
WO2007026035A3 true WO2007026035A3 (en) | 2007-05-10 |
Family
ID=37809229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/000488 WO2007026035A2 (en) | 2005-08-31 | 2006-08-28 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
Country Status (2)
Country | Link |
---|---|
ES (6) | ES2301434B1 (en) |
WO (1) | WO2007026035A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2317741B1 (en) * | 2006-06-20 | 2010-02-10 | Universidad De Malaga | COMPOSITION FOR SOLAR PROTECTION BASED ON ALGAE AND LIQUEN EXTRACTS. |
KR102196422B1 (en) * | 2019-07-15 | 2020-12-30 | 주식회사 바이오에프디엔씨 | Method of cell reprogramming adult cell to induced pluripotent stem cell using Porphyra334 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000024369A1 (en) * | 1998-10-23 | 2000-05-04 | Nouvab Inc | Solar radiation protection composition |
WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655268B1 (en) * | 1989-12-06 | 1994-10-14 | Secma | USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS. |
FR2803201B1 (en) * | 1999-12-30 | 2004-11-26 | Gelyma | ALGAE EXTRACT WITH FILTERING ACTIVITY WITH RESPECT TO ULTRAVIOLET RADIATION |
ATE420623T1 (en) * | 2001-11-14 | 2009-01-15 | Larena | MEDIUM CONTAINING A RED ALGAE EXTRACT OF THE GENUS PORPHYRA AND ITS USE TO PROTECT CELLS |
FR2882894B1 (en) * | 2005-03-11 | 2009-04-03 | Larena Sa | SUPPLETIVE FOOD COMPOSITION |
-
2005
- 2005-08-31 ES ES200702944A patent/ES2301434B1/en active Active
- 2005-08-31 ES ES200702946A patent/ES2301436B1/en active Active
- 2005-08-31 ES ES200502161A patent/ES2301293B1/en active Active
- 2005-08-31 ES ES200702943A patent/ES2301433A1/en active Pending
- 2005-08-31 ES ES200702945A patent/ES2301435B1/en active Active
- 2005-08-31 ES ES200702947A patent/ES2301437B1/en active Active
-
2006
- 2006-08-28 WO PCT/ES2006/000488 patent/WO2007026035A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000024369A1 (en) * | 1998-10-23 | 2000-05-04 | Nouvab Inc | Solar radiation protection composition |
WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
Also Published As
Publication number | Publication date |
---|---|
ES2301433A1 (en) | 2008-06-16 |
ES2301434B1 (en) | 2009-05-01 |
ES2301436A1 (en) | 2008-06-16 |
ES2301435B1 (en) | 2009-05-01 |
ES2301435A1 (en) | 2008-06-16 |
ES2301437B1 (en) | 2009-05-01 |
ES2301437A1 (en) | 2008-06-16 |
ES2301293B1 (en) | 2009-05-01 |
WO2007026035A2 (en) | 2007-03-08 |
ES2301436B1 (en) | 2009-05-08 |
ES2301293A1 (en) | 2008-06-16 |
ES2301434A1 (en) | 2008-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005082927A3 (en) | Antihypertensive peptides | |
WO2003041679A3 (en) | Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells | |
WO2011100763A3 (en) | Ruminant dietary supplement compositions and methods of manufacturing and using the same | |
WO2008036932A3 (en) | Compositions and methods comprising boswellia species | |
WO2007079139A3 (en) | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
WO2007059715A3 (en) | Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses | |
WO2004087203A3 (en) | Immunostimulatory nucleic acid oil-in-water formulations for topical application | |
WO2006042661A3 (en) | Oligopeptides and their use in cosmetics | |
CO5700787A2 (en) | COMPOSITIONS WITH A CONTENT OF ENZYMES, DIETETIC FOODS AND MEDICINES PRODUCED FROM THEM, AND ITS USE FOR MEDICINAL PURPOSES | |
WO2006034172A3 (en) | GLYCININ-RICH AND β-CONGLYCININ-RICH VEGETABLE PROTEIN FRACTIONS | |
ATE402143T1 (en) | METHOD FOR OBTAINING NEW LUTEIN-BASED FORMULATIONS | |
HUP0400563A2 (en) | Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate | |
JP2011246425A (en) | Soybean protein hydrolyzate-containing antioxidant | |
WO2006109194A3 (en) | Chromium-fatty acid compounds and methods of making and using thereof | |
DE602004012289D1 (en) | BIOACTIVE PEPTIDES OBTAINED BY ENZYMATIC HYDROLYSIS FROM THE PROTEINS OF EGG WHITE | |
WO2007137297A3 (en) | Foods and beverages with additives | |
WO2007125562A3 (en) | Method for the preparation and use of an enriched cyanidine-s-o-beta-glucopyranoside extract and derivatives thereof from fruits and vegetables containing said anthocyanin and method for the purification and use of cyanidine-3-o-beta- glucopyranoside and derivatives thereof obtained | |
WO2007026035A3 (en) | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant | |
NZ585092A (en) | Food material for inhibiting osteoclastogenesis | |
WO2003050067A3 (en) | Vitamin d analogues | |
WO2009037183A3 (en) | Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia | |
WO2007014379A3 (en) | A lipidic extract from lepidium meynii and its effect on the libido | |
WO2010090498A3 (en) | Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function | |
WO2007026036A3 (en) | Use of a mycosporin-type amino acid (m-gly) as an antioxidant | |
WO2007026038A3 (en) | Use of a mycosporin-type amino acid (shinorine) as an antioxidant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06807933 Country of ref document: EP Kind code of ref document: A2 |